Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc (JAZZ) Revenue
Annual & quarterly revenue history · segment & region breakdown
JAZZ · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsJazz Pharmaceuticals plc trailing twelve-month (TTM) revenue is $4.44B, an increase of 4.88% year-over-year from $4.27B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $4.27B | +$0.20B | +4.88% |
| 2024-12-31 | $4.07B | +$0.23B | +6.12% |
| 2023-12-31 | $3.83B | +$0.17B | +4.78% |
| 2022-12-31 | $3.66B | +$0.57B | +18.26% |
| 2021-12-31 | $3.09B | +$0.73B | +30.91% |
| 2020-12-31 | $2.36B | +$0.20B | +9.34% |
| 2019-12-31 | $2.16B | +$0.27B | +14.32% |
| 2018-12-31 | $1.89B | +$0.27B | +16.82% |
| 2017-12-31 | $1.62B | +$0.13B | +8.79% |
| 2016-12-31 | $1.49B | +$0.16B | +12.32% |
Compare revenue vs peers
BiotechnologyCompare JAZZ revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Jazz Pharmaceuticals plc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Jazz Pharmaceuticals plc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Jazz Pharmaceuticals plc's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
JAZZ revenue · 4 questionsJAZZ's trailing twelve-month (TTM) revenue is $4.44B. That is an increase of 4.88% year-over-year from $4.27B in FY2025.
▸ Source: FMP · Jazz Pharmaceuticals plc SEC filings · GAAP · Jazz Pharmaceuticals plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026